These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 25132836)

  • 1. Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation.
    Wang JQ; Jeelall YS; Ferguson LL; Horikawa K
    Front Immunol; 2014; 5():367. PubMed ID: 25132836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gain-of-Function Mutations in the Toll-Like Receptor Pathway: TPL2-Mediated ERK1/ERK2 MAPK Activation, a Path to Tumorigenesis in Lymphoid Neoplasms?
    Rousseau S; Martel G
    Front Cell Dev Biol; 2016; 4():50. PubMed ID: 27303665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
    Li TT; Ogino S; Qian ZR
    World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern recognitions receptors in immunodeficiency disorders.
    Mortaz E; Adcock IM; Tabarsi P; Darazam IA; Movassaghi M; Garssen J; Jamaati H; Velayati A
    Eur J Pharmacol; 2017 Aug; 808():49-56. PubMed ID: 28095323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MyD88 L265P mutation and B cell tumor].
    Chen HM; Hou J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):241-4. PubMed ID: 24598687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting pattern-recognition receptors to discover new small molecule immune modulators.
    Zhu G; Xu Y; Cen X; Nandakumar KS; Liu S; Cheng K
    Eur J Med Chem; 2018 Jan; 144():82-92. PubMed ID: 29268133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors in lymphoid malignancies: double-edged sword.
    Harsini S; Beigy M; Akhavan-Sabbagh M; Rezaei N
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):262-83. PubMed ID: 24051205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.
    Barnes M; Sharma P; Kumar V; Kaell A; LiPera W
    J Med Case Rep; 2020 Jul; 14(1):98. PubMed ID: 32654665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MyD88 Regulates the Expression of SMAD4 and the Iron Regulatory Hormone Hepcidin.
    Samba-Mondonga M; Calvé A; Mallette FA; Santos MM
    Front Cell Dev Biol; 2018; 6():105. PubMed ID: 30234111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-Like Receptors Signaling in the Tumor Microenvironment.
    McCall KD; Muccioli M; Benencia F
    Adv Exp Med Biol; 2020; 1223():81-97. PubMed ID: 32030686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic Acid-Sensing Toll-Like Receptors Play a Dominant Role in Innate Immune Recognition of Pneumococci.
    Famà A; Midiri A; Mancuso G; Biondo C; Lentini G; Galbo R; Giardina MM; De Gaetano GV; Romeo L; Teti G; Beninati C
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209688
    [No Abstract]   [Full Text] [Related]  

  • 13. The Role of Toll-Like Receptors in Hematopoietic Malignancies.
    Monlish DA; Bhatt ST; Schuettpelz LG
    Front Immunol; 2016; 7():390. PubMed ID: 27733853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors and their signaling mechanisms.
    Akira S; Sato S
    Scand J Infect Dis; 2003; 35(9):555-62. PubMed ID: 14620134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
    Tartey S; Takeuchi O
    Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation.
    Liu-Bryan R; Scott P; Sydlaske A; Rose DM; Terkeltaub R
    Arthritis Rheum; 2005 Sep; 52(9):2936-46. PubMed ID: 16142712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern Recognition Receptors in Cancer Progression and Metastasis.
    Pandey S; Singh S; Anang V; Bhatt AN; Natarajan K; Dwarakanath BS
    Cancer Growth Metastasis; 2015; 8():25-34. PubMed ID: 26279628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic and extrinsic regulation of innate immune receptors.
    Jeong E; Lee JY
    Yonsei Med J; 2011 May; 52(3):379-92. PubMed ID: 21488180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.